Related Experiment Video
Updated: May 28, 2026

Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
Computed Tomography-Derived Nakata Index as a Predictor of Functional Impairment in Chronic Obstructive Pulmonary
Şahhan Kılıç1, Süha Asal1, Kenan Kadirli2
1Department of Cardiology, Ministry of Health Çorlu State Hospital, Çorlu, Tekirdağ.
Purpose:
Pulmonary vascular remodeling is a key factor in chronic obstructive pulmonary disease (COPD) progression, but noninvasive prognostic markers are limited. This study assessed whether the computed tomography (CT)-derived Nakata index, a measure of body surface area-adjusted pulmonary arterial cross-sectional area, predicts functional impairment in COPD patients.
Materials And Methods:
This retrospective cohort study included 82 COPD patients who underwent thoracic CT and six-minute walk testing (6MWT) from 2023 to 2025. Patients were divided into severely impaired (<334 m, n=18) and less impaired (≥334 m, n=64) groups based on 6MWT distance. Nakata index, pulmonary artery diameters, McGoon ratio, and echocardiographic parameters were evaluated. Multivariate logistic regression identified predictors of severe functional impairment, and receiver operating characteristic (ROC) analysis determined optimal thresholds.
Results:
Severely impaired patients had a higher Nakata index (395 vs. 330 mm2/m2, P<0.001) and larger left (21.5 vs. 19 mm, P=0.002) and right (22.2 vs. 20 mm, P=0.004) pulmonary artery diameters. Multivariate analysis identified elevated Nakata index (odds ratio: 1.0110, P=0.036), increased left pulmonary artery diameter (odds ratio: 1.3683, P=0.038), and enlarged left atrial diameter (odds ratio: 1.1075, P=0.015) as independent predictors of severe impairment. A Nakata index >373 mm2/m2 showed optimal discriminatory performance (area under the curve: 0.791, sensitivity: 75%, and specificity: 72%).
Conclusions:
CT-derived Nakata index is independently associated with severe functional impairment in chronic obstructive pulmonary disease, offering superior discriminatory value over simple diameter measurements. This marker may enhance risk stratification and guide treatment strategies.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
